Vesalius bags €65M biotech fund while Novartis vet Guidi canvases for a €50M gamble on Italian scientists
The Luxembourg-based biotech venture firm Vesalius Biocapital has raised more than €65 million for its third fund, which will remain open in search of additional …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
